Senhwa Biosciences Statistics
Total Valuation
TPEX:6492 has a market cap or net worth of TWD 3.17 billion. The enterprise value is 2.30 billion.
Market Cap | 3.17B |
Enterprise Value | 2.30B |
Important Dates
The last earnings date was Friday, August 8, 2025.
Earnings Date | Aug 8, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
TPEX:6492 has 89.19 million shares outstanding. The number of shares has decreased by -0.06% in one year.
Current Share Class | 89.19M |
Shares Outstanding | 89.19M |
Shares Change (YoY) | -0.06% |
Shares Change (QoQ) | -0.10% |
Owned by Insiders (%) | 2.04% |
Owned by Institutions (%) | 0.11% |
Float | 68.82M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | 3,170.55 |
PB Ratio | 3.51 |
P/TBV Ratio | 3.51 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | -8.27 |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 38.38, with a Debt / Equity ratio of 0.03.
Current Ratio | 38.38 |
Quick Ratio | 38.11 |
Debt / Equity | 0.03 |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | -466.27 |
Financial Efficiency
Return on equity (ROE) is -26.64% and return on invested capital (ROIC) is -17.08%.
Return on Equity (ROE) | -26.64% |
Return on Assets (ROA) | -16.84% |
Return on Invested Capital (ROIC) | -17.08% |
Return on Capital Employed (ROCE) | -31.72% |
Revenue Per Employee | n/a |
Profits Per Employee | n/a |
Employee Count | n/a |
Asset Turnover | 0.00 |
Inventory Turnover | n/a |
Taxes
In the past 12 months, TPEX:6492 has paid 1.28 million in taxes.
Income Tax | 1.28M |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -26.06% in the last 52 weeks. The beta is 0.82, so TPEX:6492's price volatility has been lower than the market average.
Beta (5Y) | 0.82 |
52-Week Price Change | -26.06% |
50-Day Moving Average | 34.21 |
200-Day Moving Average | 39.63 |
Relative Strength Index (RSI) | 55.10 |
Average Volume (20 Days) | 215,400 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, TPEX:6492 had revenue of TWD 1.00 million and -278.44 million in losses. Loss per share was -3.12.
Revenue | 1.00M |
Gross Profit | 530,000 |
Operating Income | -291.88M |
Pretax Income | -277.16M |
Net Income | -278.44M |
EBITDA | -289.74M |
EBIT | -291.88M |
Loss Per Share | -3.12 |
Balance Sheet
The company has 894.14 million in cash and 26.22 million in debt, giving a net cash position of 867.92 million or 9.73 per share.
Cash & Cash Equivalents | 894.14M |
Total Debt | 26.22M |
Net Cash | 867.92M |
Net Cash Per Share | 9.73 |
Equity (Book Value) | 903.07M |
Book Value Per Share | 10.14 |
Working Capital | 877.19M |
Cash Flow
Operating Cash Flow | -265.58M |
Capital Expenditures | n/a |
Free Cash Flow | n/a |
FCF Per Share | n/a |
Margins
Gross Margin | 53.00% |
Operating Margin | -29,188.30% |
Pretax Margin | -27,716.40% |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |
Dividends & Yields
TPEX:6492 does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | 0.06% |
Shareholder Yield | n/a |
Earnings Yield | -8.78% |
FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
Lynch Fair Value | n/a |
Lynch Upside | n/a |
Graham Number | n/a |
Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
TPEX:6492 has an Altman Z-Score of 57.37 and a Piotroski F-Score of 1.
Altman Z-Score | 57.37 |
Piotroski F-Score | 1 |